author-photo

Tracie Saunders

Rutgers University

10

Papers

292

Citations

Citation Trend

Filter By

Papers (9) Sort By

Journal Conference Others

Safety and enhanced immunostimulatory activity of the DRD2 antagonist ONC201 in advanced solid tumor patients with weekly oral administration

2019 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (21)
Immune Activation and Benefit From Avelumab in EBV-Positive Gastric Cancer

2018 Journal of the National Cancer Institute
Show All
- Source
- Cite
- Save
Citations (95)
Clinical activity of the selective DRD2 antagonist ONC201, an imipridone, in metastatic endometrial cancer (mEC).

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
First-in-Human Clinical Trial of Oral ONC201 in Patients with Refractory Solid Tumors

2017 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (69)
Anticancer and immunostimulatory activity of the imipridone ONC201, a selective DRD2 antagonist, in advanced cancer patients.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
First-in-human trial of ONC201 in patients with refractory solid tumors.

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (3)
A pilot phase II trial of all-trans retinoic acid (Vesanoid) and paclitaxel (Taxol) in patients with recurrent or metastatic breast cancer

2011 Investigational New Drugs
Show All
- Source
- Cite
- Save
Citations (52)
Phase I Trial of Pegylated Liposomal Doxorubicin with Hyperthermic Intraperitoneal Chemotherapy in Patients Undergoing Cytoreduction for Advanced Intra-abdominal Malignancy

2008 Annals of Surgical Oncology
Show All
- Source
- Cite
- Save
Citations (42)
Phase I/II trial of accutane as a potentiator of carboplatin and paclitaxel in squamous cell carcinomas.

2002 American Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (7)